Format

Send to:

Choose Destination
See comment in PubMed Commons below
BMJ Case Rep. 2013 Mar 6;2013. pii: bcr2013008688. doi: 10.1136/bcr-2013-008688.

Successful experimental treatment of congenital ichthyosis in an infant.

Author information

  • 1Department of Family Medicine, University of North Carolina, Chapel Hill, North Carolina, USA. brandy.deffenbacher@ucdenver.edu

Abstract

Ichthyosis is a rare genetic disease that causes defects in skin keratinisation. Infants born with this disease have tight shiny skin that inhibits limb and ear mobilities, eyelid and lip deformities and poor hair and nail growths. In addition, the barrier properties of the skin are disrupted, which leads to dehydration, body temperature regulation difficulties and increased susceptibility to infection. The treatments currently available include topical keratolytics, emollients, and for severe disease systemic retinoids. Given the increased permeability of the skin and increased body surface area infants are particularly susceptible to accidental overdose from the topical keratolytic treatments currently available. An experimental emollient of 10% N-acetylcysteine (NAC) and 5% urea was recently used with success in Argentina. A newborn with congenital ichthyosis cared for in our clinic failed his initial treatment of topical emollients. He was subsequently treated successfully with off-label use of a topical 5% NAC and 5% urea emollient.

PMID:
23470675
[PubMed - indexed for MEDLINE]
PMCID:
PMC3618798
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for HighWire Icon for PubMed Central
    Loading ...
    Write to the Help Desk